Literature DB >> 23171900

[Chronic granulomatous disease: pathogenesis and therapy of associated fungal infections].

Anne Desjardins1, Hélène Coignard-Biehler, Nizar Mahlaoui, Pierre Frange, Marie-Elisabeth Bougnoux, Stéphane Blanche, Alain Fischer, Sophie Blumental, Olivier Lortholary.   

Abstract

Chronic granulomatous disease is a genetic disorder responsible for a defect in the NADPH oxidase of phagocytic cells. It impairs the oxidative burst necessary to the intracellular inactivation of microorganisms and predisposes to an increased risk of infections by various microorganisms, including fungi like Aspergillus spp. and other less frequently encountered or emerging fungal species. Here we review the genetic basis, pathogenesis and clinical presentation associated with fungal infections in chronic granulomatous disease as well as the current prophylaxis and newly available therapies.
© 2012 médecine/sciences – Inserm / SRMS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23171900     DOI: 10.1051/medsci/20122811015

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  2 in total

Review 1.  Chronic granulomatous disease: why an inflammatory disease?

Authors:  P Roxo-Junior; H M L Simão
Journal:  Braz J Med Biol Res       Date:  2014-08-29       Impact factor: 2.590

2.  Identification of a Novel Mutation in the CYBB Gene, p.Asp378Gly, in a Patient With X-linked Chronic Granulomatous Disease.

Authors:  Sang-Mi Song; Mi-Ran Park; Do-Soo Kim; Jihyun Kim; Yae-Jean Kim; Chang-Seok Ki; Kangmo Ahn
Journal:  Allergy Asthma Immunol Res       Date:  2014-01-20       Impact factor: 5.764

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.